ONCOTRAX 7 5 TAB

About

Oncotrax 7.5 mg is a potent antimetabolite and immunosuppressant medication, primarily used in the treatment of various cancers and severe autoimmune diseases. It works by inhibiting dihydrofolate reductase, an enzyme crucial for the synthesis of purine and pyrimidine nucleotides, which are essential building blocks for DNA and RNA. This inhibition disrupts cell proliferation, particularly in rapidly dividing cells like cancer cells and immune cells. In oncology, it acts as a chemotherapeutic agent, while in autoimmune conditions such as rheumatoid arthritis or psoriasis, it modulates the immune response to reduce inflammation and disease progression. The 7.5 mg dosage is typically used for non-oncological indications, often administered weekly, requiring careful monitoring due to its narrow therapeutic index.

Uses

• Treatment of severe active rheumatoid arthritis
• Management of severe, recalcitrant psoriasis
• Treatment of certain types of cancer (e.g., acute lymphoblastic leukemia)
• Management of other autoimmune conditions as prescribed

Directions For Use

Take exactly as prescribed by your doctor, usually once weekly on a specific day. Do not take daily. Swallow the tablet whole.

Benefits

• Effective in controlling autoimmune disease progression
• Reduces inflammation and pain in rheumatoid arthritis
• Clears psoriatic skin lesions
• Potent anti-cancer activity
• Can reduce the need for other medications
• Improves long-term disease outcomes

Side Effects

• Nausea
• Vomiting
• Diarrhea
• Stomatitis (mouth sores)
• Hair loss
• Fatigue
• Headache
• Dizziness
• Liver enzyme elevation
• Bone marrow suppression
• Increased infection risk
• Pulmonary fibrosis (rare)

Safety Measures

• Alcohol - Strictly avoid alcohol consumption as it significantly increases the risk of liver toxicity and damage when taken with Methotrexate.
• Pregnancy - Absolutely contraindicated. Methotrexate is highly teratogenic and can cause severe birth defects or fetal death.
• Breastfeeding - Contraindicated. Methotrexate is excreted in breast milk and can cause serious adverse effects in the infant.
• Liver - Contraindicated in patients with severe liver disease. Regular monitoring of liver function is essential during treatment.
• Kidney - Use with extreme caution and significant dose adjustment in patients with impaired kidney function, as it is primarily renally excreted.
• Lung - Use with caution in patients with pre-existing lung disease, as Methotrexate can cause severe pulmonary toxicity, including fibrosis.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.